IP Library › Assignment 062083/0646
Patent Assignment
Reel/Frame 062083/0646

Assignment of Assignor's Interest

Recorded: 2022-12-14 Pages: 3
Assignor
NOVARTIS AG
Executed: 2016-06-15
Assignee
GLAXOSMITHKLINE BIOLOGICALS SA
RUE DE I'INSTITUT 89, RIXENSART, 1330, BELGIUM
Covered Properties (12)
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/065,069 →
Publication: US 2023/0117413
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/065,076 →
Publication: US 2023/0110963
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/065,083 →
Publication: US 2023/0110155
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/065,089 →
Publication: US 2023/0114607
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/065,095 →
Publication: US 2023/0181618
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/065,100 →
Publication: US 2023/0114029
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/065,106 →
Publication: US 2023/0112475
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/065,109 →
Publication: US 2023/0111638
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/065,111 →
Publication: US 2023/0111016
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/080,075 →
Publication: US 2023/0105639
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/080,090 →
Publication: US 2023/0117454
Delivery of Rna to Trigger Multiple Immune Pathways
Application: 18/080,101 →
Publication: US 2023/0116636
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 14, 2022
From: GEALL, ANDREW; RAMSAUER, KATRIN; OTTEN, GILLIS; MANDL, CHRISTIAN
To: NOVARTIS VACCINES AND DIAGNOSTICS
Reel/Frame 062083/0469 →
Assignment of Assignor's Interest Dec 14, 2022
From: NOVARTIS VACCINES AND DIAGNOSTICS
To: NOVARTIS AG
Reel/Frame 062083/0570 →